Patient Flow Simulation and Market Virtualization Forecasting
For over two decades Lexidyne has been a pioneer in the field of Patient Flow Simulation and Market Virtualization. Our simulation models provide a virtual market that tracks individual patients through their therapy journey. These holistic models integrate a wide variety of insights into a single structure and help drive accurate forecasts and meaningful strategic insights.
Our models include:
- Line of Therapy New Patient Start Forecasts through 2050
- Clinical State Driven Market Map Segmentation
- Targeted Therapeutic Dynamics with Mutation and Expression
- Comprehensive Segmentation for Label Alignment and Assessment
- Advanced Front Line Epidemiology Assessment
- Cross Line Cannibalization Analysis
- Portfolio Assessment Within and Across Indications
Our models also incorporate various forms of disparate data and integrate them into one cohesive framework:
- Top Level Epidemiology
- Patient Level Claims and/or EMR Data
- Syndicated Reports
- Pivotal Trial PFS and OS
- Primary Research
We have created 100’s of models for clients that include the majority of the top 10 pharmaceutical companies by market cap, as well as many mid-cap and smaller biotech companies. We would love to learn more about your current market simulation needs, and show your team what patient flow simulation can do for your organization. Please reach out and we can schedule a time for a capabilities presentation.
